Key result
The presence of the ATR1 C allele was significantly associated with a more than four-fold increased risk of essential hypertension compared to the A allele (OR 4.313).
Why the study?
Does the ATR1 (A1166C) gene polymorphism increase the risk of essential hypertension in an Egyptian population?
Case-Control (n=143)
No
Does the ATR1 (A1166C) gene polymorphism increase the risk of essential hypertension in an Egyptian population?
The ATR1 (A1166C) gene polymorphism, specifically the C allele, is significantly associated with an increased risk of essential hypertension in the Egyptian population.
The pathogenesis of essential hypertension (EH) is affected by genetic and environmental factors. Mutations in hypertension-related genes can affect blood pressure (BP) via alteration of salt and water reabsorption by the nephron. The genes of the renin-angiotensin system (RAS) have been extensively studied because of the well documented role of this system in the control of BP. It has been previously shown that Angiotensin II type 1 receptor (ATR1) gene polymorphism could be associated with increased risk of EH. So, in the current study, we evaluated the frequency of ATR1 (A1166C) polymorphism in relation to EH in a group of Egyptian population. The study population included 83 hypertensive patients and 60 age and sex matched healthy control subjects. Restriction fragment length polymorphism – Polymerase chain reaction (RFLP – PCR) was used for the analysis of A1166C polymorphism of ATR1 genes in peripheral blood samples of all patients and controls. The results revealed that there was a positive risk of developing EH when having the T allele whether in homozygous or heterozygous state. From this work, it was concluded that there was an association between ATR1 (A1166C) gene polymorphism and the risk of developing EH.
No takes yet. Share an insight, caveat, or question.
A 2015 study conducted a case-control in Essential hypertension (n=143). ATR1 (A1166C) C allele vs. ATR1 (A1166C) A allele was evaluated on Essential hypertension (OR 4.313, 95% CI 1.84-10.09, p=<0.001). The presence of the ATR1 C allele was significantly associated with a more than four-fold increased risk of essential hypertension compared to the A allele (OR 4.313).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: